Anne Bruinvels joins EPEMED as executive director
Targeted with growing start-up organisation and building its strategic framework
Bruinvels will be responsible for growing the start-up organisation and, together with the board of directors, for building its strategic framework in creating guidance for all those involved in progressing personalised medicine with an emphasis on European market challenges.
‘I'm delighted to join EPEMED's board and to lead the association to facilitate the development and introduction of personalised medicine in Europe. I'm looking forward to working with the different parties worldwide involved in making real progress in this field,’ said Bruinvels.
Bruinvels started her work in personalised medicine more than 10 years ago. She previously founded Elixior, a personalised healthcare advisory company and prior to that Curidium, a personalised medicine company identifying companion diagnostics and therapeutics to treat patients with central nervous system disorders. She was Curidium's ceo for more than six years and raised several rounds of funding before taking the company public on the AIM of the London Stock Exchange.
Bruinvels has also worked in research for various pharmaceutical companies, including SmithKline Beecham, Wyeth and Sandoz Pharma.
You may also like
Medical Devices
Biocomposites gains MDR certification for STIMULAN antibiotic carriers
Biocomposites has secured EU MDR certification for its STIMULAN Rapid Cure and STIMULAN Kit products, enabling them to be mixed with multiple Gram-positive and Gram-negative antibiotics for infection management in bone and soft tissue
Digital
Shimadzu introduces a new site for its portfolio of LIB solutions
The website especially targets battery cell manufacturers, e-vehicle OEMs, research institutions as well as recycling companies and start-ups. There they will find Shimadzu’s latest solutions in the LIB market, including in-depth background information such as brochures and FAQs as well as featured highlight products